These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16952882)

  • 1. Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?
    Fahr A; van Hoogevest P; Kuntsche J; Leigh ML
    J Liposome Res; 2006; 16(3):281-301. PubMed ID: 16952882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
    Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
    Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
    Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
    J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery strategies for poorly water-soluble drugs.
    Fahr A; Liu X
    Expert Opin Drug Deliv; 2007 Jul; 4(4):403-16. PubMed ID: 17683253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Liposomes for Enhancement of Oral Drug Absorption.
    Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
    Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of liposomes for studying drug transfer and uptake.
    Fahr A; Liu X
    Methods Mol Biol; 2010; 606():1-10. PubMed ID: 20013385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of asymmetrical flow field-flow fractionation with on-line detection in the study of drug retention within liposomal nanocarriers and drug transfer kinetics.
    Hinna AH; Hupfeld S; Kuntsche J; Brandl M
    J Pharm Biomed Anal; 2016 May; 124():157-163. PubMed ID: 26950903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome formulations of hydrophobic drugs.
    Schwendener RA; Schott H
    Methods Mol Biol; 2010; 605():129-38. PubMed ID: 20072877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 11. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
    Cherniakov I; Domb AJ; Hoffman A
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H; Holm R; Müllertz A
    Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P; Liu X; Fahr A
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1481-500. PubMed ID: 21895540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome Formulations of Hydrophobic Drugs.
    Schwendener RA; Schott H
    Methods Mol Biol; 2017; 1522():73-82. PubMed ID: 27837531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
    Zhang Z; Gao F; Jiang S; Ma L; Li Y
    Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: In silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects.
    Baldi A; Chaudhary M; Sethi S; Abhiav ; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2018 Oct; 170():637-647. PubMed ID: 29986259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.